Several years ago, a little-known drug named Ozempic — previously used only to treat diabetes — emerged as a promising new ...

Researchers have provided the molecular explanation for why some osteoporosis drugs offer protection against COVID-19. The study, by researchers at the University of York, builds on work conducted ...

In drug discovery, very little of what’s learned ... the cell — an approach that was later used in the mRNA-based COVID-19 vaccines — and then via conjugates: molecules that link to siRNAs ...

and the company plans to file an investigational new drug application with the US Food and Drug Administration (FDA) this year, and initiate Phase I clinical trials. If successful, the therapeutic ...

UK’s former vaccine tsar says immunocompromised people were ‘de-prioritised’ in a ‘two-tier’ therapeutic rollout strategy ...

Shionogi will receive $375 million to develop a long-acting protease inhibitor designed to prevent SARS-CoV-2 infection in people who are immune compromised.

The global generic drugs market revenue was around US$ 416.5 billion in 2023 and is estimated to reach US$ 839.5 billion by 2032, growing at a compound annual growth rate (CAGR) of 8.1% during the ...

a comprehensive understanding of these aspects is crucial for establishing the therapeutic potential of cannabinoids and ECS modulation on the onset of COVID-19 and lingering symptoms associated ...

AIM therefore believes that any future trial design should focus on Ampligen’s therapeutic potential for subjects who’s ... immune disorders and viral diseases, including COVID-19. The Company’s lead ...

MINNEAPOLIS (FOX 9) - A study done by the University of Minnesota (U of M) found that early adult deaths are on the rise in the U.S., with COVID-19 and drug overdoses being the main causes.